Keywords: سالمترولول; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
مقالات ISI سالمترولول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سالمترولول; Fluticasone propionate; Salmeterol; Unit-dose inhaler; Multi-dose inhaler; Asthma; Non-inferiority;
Keywords: سالمترولول; Asthma; small airways; spirometry; impulse oscillometry; long-acting β-agonist; formoterol; salmeterol; ACQ; Asthma Control Questionnaire; AX; Reactance area under the curve; FEF25-75; Forced midexpiratory flow between 25% and 75% of forced vital capacit
Keywords: سالمترولول; AHR; airway hyperresponsiveness; ACQ; Asthma Control Questionnaire; ACOS; asthma-COPD overlap syndrome; BAL; bronchoalveolar lavage; CLCA1; chloride channel regulator 1; COPD; chronic obstructive lung disease; CS; corticosteroids; CXCR; CXC chemokine rece
Keywords: سالمترولول; LABA; Formoterol; Salmeterol; Chronic obstructive pulmonary disease; Asthma
Keywords: سالمترولول; Asthma; tiotropium; salmeterol; responder analysis; predictor of response; ACD; Asthma control day; ACRN; Asthma Clinical Research Network; FVC; Forced vital capacity; HFA; Hydrofluoroalkane; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LAMA
Technical challenges in obtaining an optimized powder/DPI combination for inhalation delivery of a bi-component generic drug
Keywords: سالمترولول; DPI; Generic drugs; Product development; Inhalation; Fluticasone; Salmeterol; Fluticasone propionate (PubChem CID: 444036); Salmeterol (PubChem CID: 5152); Lactose monohydrate (PubChem CID: 57654326);
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma
Keywords: سالمترولول; Fluticasone propionate; Salmeterol; Unit-dose inhaler; Multi-dose inhaler; Asthma; Non-inferiority
Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy
Keywords: سالمترولول; Asthma; Chronic obstructive pulmonary disease; Combination therapy; Fluticasone propionate; Persistence; Retrospective analysis; Salmeterol; COPD; Chronic obstructive pulmonary disease; ISPOR; The International Society for Pharmacoeconomics and Outcomes R
Evaluation of the anti-inflammatory effects of β-adrenoceptor agonists on human lung macrophages
Keywords: سالمترولول; Alveolar macrophages; β-agonists; TNFα; Indacaterol; Salmeterol;
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
Keywords: سالمترولول; COPD; Fluticasone propionate; Salmeterol; Umeclidinium; Vilanterol;
Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A
Keywords: سالمترولول; Long-acting β2-agonist; salmeterol; formoterol; salbutamol; asthma; allergy; rhinovirus; exacerbation; chemokine; dexamethasone; (S)-2-amino-4-(4-[heptyloxy]phenyl)-2-methylbutan-1-ol; protein phosphatase 2A; nuclear factor κB; AAD; Allergic airways dis
Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler
Keywords: سالمترولول; Fluticasone propionate; Salmeterol; Dry powder inhaler; Rotacaps; Rotahaler; Diskus
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients
Keywords: سالمترولول; COPD; Tiotropium; Salmeterol; Exacerbations; GOLD stage II; Maintenance therapy;
Effect of formulation ingredients on the physical characteristics of salmeterol xinafoate microparticles tailored by spray freeze drying
Keywords: سالمترولول; Salmeterol; Spray freeze drying; Cyclodextrin; Dissolution
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
Keywords: سالمترولول; COPD; Formoterol; Indacaterol; Salmeterol; Tiotropium
Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: A pilot study
Keywords: سالمترولول; COPD; Bronchodilator agents; Salmeterol
Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells
Keywords: سالمترولول; Roflumilast; cAMP; PDE4; Salmeterol; PBMC; DexamethasonePDE4i, phosphodiesterase 4 inhibitor; COPD, chronic obstructive pulmonary disease; LABA, long-acting β2 adrenoceptor agonist; PBMC, peripheral blood mononuclear cells; TNFα, tumor necrosis factor-α;
Salmeterol or doxycycline do not inhibit acute bronchospasm and airway inflammation in cats with experimentally-induced asthma
Keywords: سالمترولول; Cat; Allergic bronchospasm; Acute bronchial inflammation; Salmeterol; Doxycycline
Effect of combination treatment on lung volumes and exercise endurance time in COPD
Keywords: سالمترولول; Tiotropium; Salmeterol; Fluticasone; Chronic obstructive pulmonary disease; Lung hyperinflation; Exercise endurance
Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma
Keywords: سالمترولول; Budesonide; Formoterol; Fluticasone; Salmeterol; Impulse oscillometry (IOS); Fractional exhaled nitric oxide (FeNO); Small airway
Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study
Keywords: سالمترولول; Indacaterol; Salmeterol; COPD; Bronchodilation; FEV1; Inspiratory capacity
Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents
Keywords: سالمترولول; Bronchoconstriction; Einthoven model; Guinea pig; Rat; Ipratropium; Tiotropium; Albuterol; Salmeterol; Indacaterol; Methods;
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
Keywords: سالمترولول; beta2-agonist; Bronchodilator; COPD; Indacaterol; Salmeterol
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
Keywords: سالمترولول; Indacaterol; Formoterol; Salmeterol; Tiotropium; Dyspnoea; Health status
The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor
Keywords: سالمترولول; Asthma; COPD; Bronchodilation; Salmeterol; Formoterol; IndacaterolPF610,355, (N-[(4′-Hydroxybiphenyl-3-yl)methyl]-2-[3-(2-{[(2R)-2-hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}ethyl]amino}-2-methylpropyl)phenyl]acetamide; PF613,322, N-Adamantan-1-
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD
Keywords: سالمترولول; Chronic obstructive pulmonary disease; Evening dose; Indacaterol; Morning dose; Salmeterol
Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting β2-adrenoceptor agonist exposure
Keywords: سالمترولول; Asthma; salmeterol; homologous β2-adrenergic receptor desensitization; airway smooth muscle; phosphodiesterase; ERK1/2 phosphorylation; siRNA; MAPK phosphatase 1ASM, Airway smooth muscle; β2AR, β2-Adrenergic receptor; cAMP, Cyclic adenosine monophosphate;
24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol
Keywords: سالمترولول; Asthma; Bronchodilator; Corticosteroids; Indacaterol; Salmeterol
Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness
Keywords: سالمترولول; high altitude; acute mountain sickness; high altitude pulmonary edema; high altitude cerebral edema; acetazolamide; dexamethasone; nifedipine; salmeterol; tadalafil; sildenafil
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: A multicenter, randomized study
Keywords: سالمترولول; Chronic obstructive pulmonary disease (COPD); Formoterol; Salmeterol; 6-Min walk test (6MWT); Forced expiratory volume in 1 s (FEV1)
Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall
Keywords: سالمترولول; Fluticasone propionate; salmeterol; combination; asthma; utilization; emergency department; hospitalization; exacerbations; drug holidayED, Emergency department; FSC, Fluticasone propionate plus salmeterol in a single inhaler; GEE, Generalized estimating
Asthma control over 3 years in a real-life study
Keywords: سالمترولول; Hyperresponsiveness; Asthma; Control; Fluticasone propionate; Salmeterol; Combination
QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: Model optimisation and evaluation
Keywords: سالمترولول; ECG; QA interval; LVdP/dtmax; Contractility; Verapamil; Salmeterol; Milrinone; Conscious rat; Methods
Interaction kinetics of salmeterol with egg phosphatidylcholine liposomes by surface plasmon resonance
Keywords: سالمترولول; Surface plasmon resonance (SPR); Salmeterol; Propranolol; Liposomes; Lipid bilayer; Partitioning; Kinetic; Translocation; Flip–flop; β2-Adrenoceptor agonist
Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol
Keywords: سالمترولول; Asthma; child; polymorphism; asthma exacerbations; albuterol; salmeterol; β2-adrenoceptor; adrenergic β2-receptor agonist gene; ADRB2; Adrenergic β2-receptor agonist gene; BTS; British Thoracic Society; OR; Odds ratio;
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review
Keywords: سالمترولول; Safety; Bronchodilators; Asthma; Formoterol; Salmeterol; Long-acting beta agonists; Inhaled corticosteroidsAE, asthma exacerbations; CS, corticosteroids; CI, confidence interval; FEV1, forced expiratory volume in the first second; ICS, inhaled corticoster
Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
Keywords: سالمترولول; Indacaterol; Salmeterol; Partitioning; Liposomes; Surface Plasmon Resonance (SPR); Kinetics; Membrane fluidity; Beta-2-adrenoceptor agonist; Rafts
Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study
Keywords: سالمترولول; COPD; Chronic obstructive pulmonary disease; Tiotropium; Salmeterol; Long-acting β2-agonists; Fluticasone; Bronchodilator; Inhaled corticosteroids; Forced expiratory volume in 1 s; Forced vital capacity
Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility
Keywords: سالمترولول; Chronic obstructive pulmonary disease (COPD); Fluticasone propionate; Salmeterol; Inhaled corticosteroid; Beta-agonist; Ipratropium; Albuterol; Reversibility
Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations
Keywords: سالمترولول; Fluticasone; Salmeterol; Interaction; Human plasma; Liquid chromatography; Mass spectrometry
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD
Keywords: سالمترولول; combination treatment; COPD; fluticasone; formoterol; lung function; salmeterol; tiotropiumAUC0–12, area under the curve for the time period 0 to 12 h; CI, confidence interval; FAS, full analysis set; PEFR, peak expiratory flow rate
Maintaining asthma control in persistent asthma: Comparison of three strategies in a 6-month double-blind randomised study
Keywords: سالمترولول; Persistent asthma; Fluticasone; Salmeterol; Control; Step-down strategy
Safety of Long-Acting β-Agonists in Stable COPD
Keywords: سالمترولول; bronchodilators; COPD; formoterol; long-acting β2-agonists; salmeterol; tiotropiumCI, confidence interval; ICS, inhaled corticosteroids; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LABA, long-acting β2-agonist; NNT, number need to treat;
Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily
Keywords: سالمترولول; Asthma; Long-acting beta2-agonist; Inhaled corticosteroid; Fluticasone propionate; Salmeterol; Once daily
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Keywords: سالمترولول; Chronic obstructive pulmonary disease (COPD); Salmeterol; Fluticasone propionate; Long-acting beta2-agonist; Inhaled corticosteroid; ExacerbationsCOPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FSC, fluticasone p
The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
Keywords: سالمترولول; Budesonide; Chronic obstructive pulmonary disease; Corticosteroids; Fluticasone propionate; Formoterol; Inhaled corticosteroid; Long-acting β2-Agonist; Mortality; Salmeterol
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients
Keywords: سالمترولول; Budesonide; formoterol; fluticasone propionate; salmeterol; adjustable dosing; asthma; AE; Adverse event; DPI; Dry powder inhaler; ICS; Inhaled corticosteroid; LABA; Long-acting β2-adrenergic agonist; PEF; Peak expiratory flow; pMDI; Pressurized metered-
The discovery of long acting β2-adrenoreceptor agonists
Keywords: سالمترولول; β2; Asthma; COPD; Duration of action; Salmeterol; Formoterol; Bioavailability
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting β2-agonists
Keywords: سالمترولول; Formoterol; Salmeterol; Tiotropium; Blood gases; COPD